Shaolin Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
LA
KC
MF
WAM
MC
LP
TCM
AIMCA
PAMP
PMAM
Shaolin Capital Management's TDAC Position: Q2 2026 in Review
Shaolin Capital Management reduced its Translational Development Acquisition Corp (TDAC) stake by 7.9% in Q2 2026, selling an estimated $185K and leaving 200,760 shares worth $2.15M. The position accounts for 0.1% of the portfolio, ranked #201.
Shaolin Capital Management first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.31M in Q1 2026. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.
- Shaolin Capital Management held 200,760 shares of Translational Development Acquisition Corp worth $2.15M as of Q2 2026.
- Shaolin Capital Management sold 17,334 Translational Development Acquisition Corp shares in Q2 2026, an estimated $185K.
- Translational Development Acquisition Corp made up 0.1% of Shaolin Capital Management's portfolio in Q2 2026, its #201 holding.
- Shaolin Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
- Shaolin Capital Management's Translational Development Acquisition Corp position peaked at $2.31M in Q1 2026.
- 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.
Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.